• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

NCTR Research Highlights

Red envelope icon for GovdeliveryGet e-mail updates when this information changes.


Current Highlight from September 14, 2012


Nanotoxicology 2012—September 4-7

NCTR scientists presented keynote addresses at the 6th International Conference on Nanotoxicology that was held September 4-7, 2012, in Beijing, China.  The first address focused on the activities of the FDA Nanotechnology Task force and model studies for dermal penetration of nanoscale materials; the second presentation discussed the ongoing interdisciplinary activities for the safety assessment of gold and carbon nanoparticles.  The conference was organized by the National Center for Nanoscience and Technology of China and provided an international forum for the discussion of the current understanding of the toxicity of nanomaterials.

For additional information, please contact Paul Howard, Ph.D., Director, Office of Scientific Coordination, FDA/NCTR.

SmartTots Workshop—September 10

NCTR scientists participated in a SmartTots workshop held at the FDA White Oak campus on September 10, 2012.  The workshop was called to outline a brief evidence-based message that will convey current knowledge regarding the risks of using general anesthesia and sedation in infants and children.  A consensus document will be available for distribution in the near future.  SmartTots is a public/private partnership between the FDA and the International Anesthesia Research Society (IARS).

For additional information, please contact William Slikker, Jr., Ph.D., Director, FDA/NCTR, or Merle Paule, Ph.D., Director, Division of Neurotoxicology, FDA/NCTR.
 

 

 

 

Contact FDA

870-543-7000
National Center for Toxicological Research

Food and Drug Administration

3900 NCTR Road

Jefferson, AR 72079
-
-